Substituted nucleosides, nucleotides and analogs thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9603864
SERIAL NO

14746500

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a Coronaviridae virus, a Togaviridae virus, a Hepeviridae virus and/or a Bunyaviridae virus infection with one or more nucleosides, nucleotides and nucleotide analogs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN PHARMACEUTICALS INC1125 TRENTON-HARBOURTON ROAD TITUSVILLE NJ 08560

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beigelman, Leonid San Mateo, US 390 10741
Blatt, Lawrence M Healdsburg, US 70 1601
Smith, David Bernard San Mateo, US 94 2931
Symons, Julian Alexander San Carlos, US 7 365

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00